Gilead Sciences
GILD
#127
Rank
A$226.75 B
Marketcap
A$182.75
Share price
1.24%
Change (1 day)
26.84%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: A$226.75 Billion

As of January 2026 Gilead Sciences has a market cap of A$226.75 Billion. This makes Gilead Sciences the world's 127th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$226.75 B-1.84%
2025A$231.00 B22.51%
2024A$188.56 B27.27%
2023A$148.16 B-6.36%
2022A$158.23 B25.99%
2021A$125.59 B32.24%
2020A$94.97 B-19.17%
2019A$117.49 B3.22%
2018A$113.82 B-5.04%
2017A$119.86 B-8.42%
2016A$130.88 B-33.74%
2015A$197.52 B14.41%
2014A$172.64 B33.64%
2013A$129.18 B140.64%
2012A$53.68 B79.05%
2011A$29.98 B4.79%
2010A$28.61 B-33.98%
2009A$43.33 B-34.33%
2008A$65.99 B35.01%
2007A$48.88 B28.7%
2006A$37.98 B14.99%
2005A$33.02 B62.76%
2004A$20.29 B21.37%
2003A$16.72 B40.22%
2002A$11.92 B-4.06%
2001A$12.42 B77.72%
2000A$6.99 B92.56%
1999A$3.63 B76.35%
1998A$2.05 B16.75%
1997A$1.76 B94.92%
1996A$0.90 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Gilead Sciences was reported to be:

A$226.73 Billion
by Nasdaq info icon info icon
A$226.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
A$261.29 B 15.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$176.02 B-22.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$579.68 B 155.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$33.34 B-85.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$40.59 B-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$214.16 B-5.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$753.16 B 232.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.444 T 537.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$406.53 B 79.28%๐Ÿ‡บ๐Ÿ‡ธ USA